论文部分内容阅读
目的探讨丹红注射液联合低分子肝素钙治疗脑梗塞的效果。方法本次选择120名住院的脑梗塞患者,对其进行分组,所有患者均采用常规低分子肝素钙治疗,观察组单独给予丹红注射液治疗,对照组则无。结果两组在治疗前评分无明显差别,治疗后观察组和对照组总有效率分别为84.13%、64.10%,有统计学意义(P<0.05)。治疗后各个时期观察组的NDS评分(即神经功能缺损评分)明显好于对照组(P<0.05)。结论丹红注射液联合低分子肝素钙是防治神经功能缺损、治疗脑梗塞发生的有效手段,且临床安全性较高,值得推广。
Objective To investigate the effect of Danhong injection combined with low molecular weight heparin on cerebral infarction. Methods This study selected 120 hospitalized patients with cerebral infarction, which were grouped, all patients were treated with conventional low molecular weight heparin, the observation group was given Danhong injection alone, but no in the control group. Results There was no significant difference between two groups before treatment. After treatment, the total effective rates of the observation group and the control group were 84.13% and 64.10%, respectively, with statistical significance (P <0.05). NDS scores (ie, neurological deficit scores) in the observation group were significantly better than those in the control group (P <0.05). Conclusion Danhong injection combined with low molecular weight heparin is an effective method to prevent and cure neurological deficit and to treat cerebral infarction. It is worth to be popularized because of its high clinical safety.